Clinical trial
Proton Radiotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC)
NCT00495040 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00495040 |
|---|---|
| Title | Proton Radiotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC) |
| Official title | Phase II Escalated/Accelerated Proton Radiotherapy for Inoperable Stage I (T1-T2, N0, M0) and Selected Stage II (T3N0M0) Non-Small Cell Lung Cancer (NSCLC) |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH Massachusetts General Hospital |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Radiation |
| Interventions | Proton Radiotherapy |
| Enrollment | 38 |
| Start date | May 4, 2006 |
| Primary completion | Jun 14, 2017 |
| Completion | Jun 14, 2017 |
| First posted | Jul 2, 2007 |
| Last update posted | Jan 14, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: